Management of Graves’ upper eyelid retraction (GUER): A review
Graves’ disease, a common autoimmune disorder, characteristically presents with upper eyelid retraction, causing significant functional and cosmetic concerns for affected individuals. The management of Graves’ upper eyelid retraction has evolved significantly over recent years, with various surgical...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-02-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/IJO.IJO_748_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832087210003791872 |
---|---|
author | Akruti Desai Pallavi Singh Dan Rootman Milind N. Naik |
author_facet | Akruti Desai Pallavi Singh Dan Rootman Milind N. Naik |
author_sort | Akruti Desai |
collection | DOAJ |
description | Graves’ disease, a common autoimmune disorder, characteristically presents with upper eyelid retraction, causing significant functional and cosmetic concerns for affected individuals. The management of Graves’ upper eyelid retraction has evolved significantly over recent years, with various surgical and non-surgical interventions. An ideal procedure is predictable and easily repeatable. This review provides a comprehensive overview of the contemporary approaches to managing Graves’ upper eyelid retraction, encompassing both traditional and emerging techniques. It critically evaluates the surgical options for correcting Graves’ upper eyelid retraction to achieve the desired eyelid contour, eyelid crease, tarsal platform show, and brow fat span. Their comparative effectiveness is meticulously explored, offering clinicians valuable insights into treatment selection. Moreover, this review also underscores combined orbital decompression with levator recession. Additionally, advancements in non-invasive modalities, including botulinum toxin, triamcinolone acetate injections, and hyaluronic acid fillers are discussed in detail. This review aims to facilitate informed decision-making and improve the overall outcomes for individuals affected by Graves’ disease-associated upper eyelid retraction. |
format | Article |
id | doaj-art-33879e1afdbf446b908894332418252b |
institution | Kabale University |
issn | 0301-4738 1998-3689 |
language | English |
publishDate | 2025-02-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Indian Journal of Ophthalmology |
spelling | doaj-art-33879e1afdbf446b908894332418252b2025-02-06T05:39:35ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892025-02-0173216417210.4103/IJO.IJO_748_24Management of Graves’ upper eyelid retraction (GUER): A reviewAkruti DesaiPallavi SinghDan RootmanMilind N. NaikGraves’ disease, a common autoimmune disorder, characteristically presents with upper eyelid retraction, causing significant functional and cosmetic concerns for affected individuals. The management of Graves’ upper eyelid retraction has evolved significantly over recent years, with various surgical and non-surgical interventions. An ideal procedure is predictable and easily repeatable. This review provides a comprehensive overview of the contemporary approaches to managing Graves’ upper eyelid retraction, encompassing both traditional and emerging techniques. It critically evaluates the surgical options for correcting Graves’ upper eyelid retraction to achieve the desired eyelid contour, eyelid crease, tarsal platform show, and brow fat span. Their comparative effectiveness is meticulously explored, offering clinicians valuable insights into treatment selection. Moreover, this review also underscores combined orbital decompression with levator recession. Additionally, advancements in non-invasive modalities, including botulinum toxin, triamcinolone acetate injections, and hyaluronic acid fillers are discussed in detail. This review aims to facilitate informed decision-making and improve the overall outcomes for individuals affected by Graves’ disease-associated upper eyelid retraction.https://journals.lww.com/10.4103/IJO.IJO_748_24grave’s upper eyelid retractionlevator recessionthyroid eye disease |
spellingShingle | Akruti Desai Pallavi Singh Dan Rootman Milind N. Naik Management of Graves’ upper eyelid retraction (GUER): A review Indian Journal of Ophthalmology grave’s upper eyelid retraction levator recession thyroid eye disease |
title | Management of Graves’ upper eyelid retraction (GUER): A review |
title_full | Management of Graves’ upper eyelid retraction (GUER): A review |
title_fullStr | Management of Graves’ upper eyelid retraction (GUER): A review |
title_full_unstemmed | Management of Graves’ upper eyelid retraction (GUER): A review |
title_short | Management of Graves’ upper eyelid retraction (GUER): A review |
title_sort | management of graves upper eyelid retraction guer a review |
topic | grave’s upper eyelid retraction levator recession thyroid eye disease |
url | https://journals.lww.com/10.4103/IJO.IJO_748_24 |
work_keys_str_mv | AT akrutidesai managementofgravesuppereyelidretractionguerareview AT pallavisingh managementofgravesuppereyelidretractionguerareview AT danrootman managementofgravesuppereyelidretractionguerareview AT milindnnaik managementofgravesuppereyelidretractionguerareview |